O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-10.39%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.91B
AUM Growth
+$5.91B
(-15%)
Cap. Flow
-$46.9M
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
34.46%
Holding
169
New
32
Increased
33
Reduced
28
Closed
26
Top Buys
| 1 |
Arcutis Biotherapeutics
ARQT
|
$139M |
| 2 |
Biogen
BIIB
|
$132M |
| 3 |
Passage Bio
PASG
|
$110M |
| 4 |
Pfizer
PFE
|
$98.3M |
| 5 |
Gilead Sciences
GILD
|
$85.6M |
Top Sells
| 1 |
THOR
Synthorx, Inc. Common Stock
THOR
|
$372M |
| 2 |
ARQL
Arqule Inc
ARQL
|
$99.8M |
| 3 |
Danaher
DHR
|
$98.1M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$93.8M |
| 5 |
Tandem Diabetes Care
TNDM
|
$68M |
Sector Composition
| 1 | Healthcare | 97.58% |
| 2 | Financials | 1.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRRA
76
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $14.5M | 0.24% | +1,477,320 | New | +$14.5M |
|
77
Corvus Pharmaceuticals
CRVS
$428M
| $14.3M | 0.24% | 6,767,584 | – | – |
|
78
Spyre Therapeutics
SYRE
$996M
| $13.4M | 0.22% | 2,865,524 | – | – |
|
79
Zai Lab
ZLAB
$3.68B
| $13.1M | 0.22% | 254,000 -260,000 | -51% | -$13.4M |
|
|
PFNX
80
DELISTED
Pfenex Inc.
PFNX
| $11.5M | 0.19% | 1,305,034 +690,166 | +112% | +$6.09M |
|
81
X4 Pharmaceuticals
XFOR
$84.2M
| $10.9M | 0.18% | 1,086,493 | – | – |
|
|
ALPN
82
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $10.6M | 0.18% | 3,670,955 | – | – |
|
83
Neurogene
NGNE
$264M
| $10.5M | 0.18% | 921,800 +21,800 | +2% | +$248K |
|
|
TECX
84
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $10.3M | 0.17% | 663,174 +28,474 | +4% | +$443K |
|
85
Health Care Select Sector SPDR Fund
XLV
$33.9B
| $10M | 0.17% | 113,200 | – | – |
|
86
SPDR S&P Biotech ETF
XBI
$5.07B
| $9.85M | 0.17% | 127,200 | – | – |
|
|
CTIC
87
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $8.76M | 0.15% | 9,520,600 +4,520,600 | +90% | +$4.16M |
|
88
Regenxbio
RGNX
$451M
| $8.67M | 0.15% | 267,700 +240,900 | +899% | +$7.8M |
|
|
89
Regeneron Pharmaceuticals
REGN
$61.5B
| $8.4M | 0.14% | 17,200 -192,100 | -92% | -$93.8M |
|
90
Mersana Therapeutics
MRSN
$36.5M
| $7.85M | 0.13% | 1,346,721 -726,598 | -35% | -$4.24M |
|
|
TVRD
91
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $7.83M | 0.13% | +592,800 | New | +$7.83M |
|
|
ADAP
92
Adaptimmune Therapeutics
ADAP
$15.6M
| $6.87M | 0.12% | 2,525,654 +1,174,999 | +87% | +$3.2M |
|
93
Revolution Medicines
RVMD
$7.1B
| $6.57M | 0.11% | +300,000 | New | +$6.57M |
|
94
Heron Therapeutics
HRTX
$207M
| $6.31M | 0.11% | +537,420 | New | +$6.31M |
|
|
OBSV
95
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $6.28M | 0.11% | 2,605,531 | – | – |
|
96
Cartesian Therapeutics
RNAC
$261M
| $6.25M | 0.11% | 2,593,869 -285,195 | -10% | -$687K |
|
97
Xtant Medical Holdings
XTNT
$83.3M
| $6.17M | 0.1% | 9,207,012 | – | – |
|
98
ESSA Pharma
EPIX
$11.4M
| $5.89M | 0.1% | 1,471,853 | – | – |
|
99
10x Genomics
TXG
$1.74B
| $5.78M | 0.1% | +92,700 | New | +$5.78M |
|
|
ARNA
100
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.6M | 0.09% | 133,400 +23,400 | +21% | +$983K |
|